Introduction
Renal cell cancer (RCC), as the predominant subtype of kidney cancer, is still the most common malignancy of the renal parenchyma in adults, although the incidence of kidney cancer worldwide has shown signs of stabilizing or decreasing (1) . There is a huge difference in the incidence of RCC in various countries and ratio among male to female is over 2:1 (2) . Although, the exact mechanisms of RCC are still not fully clear, epidemiological surveys have implicated that cigarette smoking, obesity, hypertension, diabetes and family history of cancer may be risk factors for RCC (3) (4) (5) .
MicroRNAs (miRNAs or miRs), a class of short non-coding RNAs, perform negative regulatory translation by binding to partially complementary sequences in the 3′-untranslated regions (3′-UTR) of target messenger RNAs (mRNAs). Critical roles of miRNAs have been demonstrated in various key biological processes including growth of organism (6) , hormone secretion (7), inflammatory reaction (8) and especially tumorigenesis (9, 10) . Moreover, miRNAs expression patterns in multiple human cancers are surprisingly informative and are able to classify human cancers, even for cancer diagnosis (11) . To date, some studies have revealed that miRNA expression profiles and some specific miRNAs were associated with RCC (12, 13) .
More recently, considerable studies have specified that genetic variations, especially single nucleotide polymorphisms (SNPs), could contribute to RCC risk and survival, such as the association of germline alterations in von Hippel-Lindau inactivation and clear-cell renal cancer (14) , and fumarate hydratase mutations related to type 2 papillary RCC (15) . It has been reported that SNPs in miRNA genes, altering miRNA processing and expression, were associated with cancer susceptibility, prognosis and survival (16) , but not been widely found in RCC.
In this study, we selected four common miRNA SNPs (i.e. miR-146a rs2910164 C>G, miR-149 rs2292832 T>C, miR-196a2 rs11614913 T>C and miR-499 rs3746444 T>C) to evaluate their associations with the risk and survival of RCC by a two-stage case-control study and a cohort study. Further functional analyses were conducted to determine SNPs effects on RCC risk and survival.
Materials and methods

Study population
Details are presented in previous ongoing study (17) . The discovery set included 355 cases and 362 controls, and the validation set recruited additional 647 RCC cases and 670 controls, which were frequency-matched to the case by age (± 5 years) and sex. Each individual donated 5 ml venous blood for genomic DNA extraction after writing informed consent. For survival analysis, 355 patients in first stage were followed up prospectively for survival information every 6 months from histological confirmation until death or last time of follow-up. Of them, 44 patients were excluded due to lack of incomplete follow-up information. Our study was approved by the institutional review board of Nanjing Medical University.
SNP selection and genotyping
Relying on 14 candidate miRNA SNPs from our previous report about bladder cancer (18), we chose the four common miRNA SNPs (i.e. rs2910164, rs2292832, rs11614913 and rs3746444 in miR-146a, -149, -196a2 and -499, respectively) and genotyped by TaqMan allelic discrimination method. The average call rates for SNPs genotyping were 99.8%. Random 10% of the samples were selected for repeated genotyping and the results were 100% concordant.
Quantitative real-time reverse transcription-polymerase chain reaction assay
A total of 26 RCC tissues were obtained from surgically removed specimens and RNAs were isolated from ~100 mg tissues using mirVana miRNA Isolation Kit (Applied Biosystems, Foster City, CA). The expression level of miR196a-5p was examined by TaqMan MicroRNA Assays (Applied Biosystems). The comparative CT method comparing to the transcription level of small nuclear RNA U6 (RNU6B) was used to evaluate the expression levels.
Prediction of potential mRNA targets of miR-196a2
The potential cancer-related mRNA targets for miR-196a-3p were predicted by computer-aided algorithms, including miRanda (19) , DIANA microT v4.0 (20) , miRDB (21) and Microcosm Targets (http://www.ebi.ac.uk/enright-srv/ microcosm). Avoiding a higher false positives, four approaches were combined together to provide a more accurate assessment of real miRNA targets. First, miRanda was as primary source for prediction to select 15 cancer-related transcripts with the highest absolute mirSVR score. Then, these transcripts were introduced into the other softwares to verify whether the same binding sites can be predicted with the best score. Finally, two RCC-related genes (NRP2 (22) and TYMS (23)) identified by four algorithms simultaneously were chosen as potential miRNA targets for further functional study. In addiction, LSP1 was included as a previously reported target of miR-196a-3p (24) .
Abbreviations: 3′-UTR, 3′-untranslated region; CI, confidence interval; miRNA, microRNA; mRNA, messenger RNA; RCC, renal cell carcinoma; SNP, single nucleotide polymorphism. † The authors contributed equally to this work. ‡These authors jointly directed this work.
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Construction of miR-196a2 expression plasmids and 3′-UTRs reporter plasmids Documented in miRBase database (25) , the sequence of miR-196a2 precursor was gene-synthesized with C or T alleles of rs11614913 which were cloned into BamHI and XhoI restrictive sites of pPG/miR/EGFP/Blasticidin expression plasmid (GenePharma Co., Ltd, Shanghai, China), shortly called pPGmiR-196a2-C or -T. Besides, human NRP2 3′-UTR (651 bps), TYMS 3′-UTR (522 bps) and LSP1 3′-UTR (561 bps) were inserted between the restrictive sites XhoI and NotI of psiCHECK™-2 reporter vector (Promega, Madison, WI), simply as psiCHECK-2-NRP2, -TYMS or -LSP1. DNA sequencing was used to confirm the accuracy of the constructed plasmids.
Transient transfections and luciferase reporter assay
The cell lines (293A, 786-0 and OS-RC-2) were cotransfected with 3′-UTR reporter plasmids and miR-196a2 expression plasmids using Lipofectamine 2000 (Invitrogen, Carlsbad, CA). Transfection efficiency was verified by fluorescence microscopy. The non-miRNA-inserted expression plasmid was used as a negative control. After transfection for 24 h, luciferase activity was measured with a Dual-Luciferase Reporter Assay System (Promega). The firefly luciferase gene serves as an intraplasmid transfection normalization reporter. Independent triplicate experiments were performed for each plasmid construct.
Statistical analysis
All statistical analyses were performed with Statistical Analysis System software (version 9.1.3; SAS Institute, Cary, NC). Differences in the distribution of selected demographic variables between RCC cases and cancer-free controls were evaluated using the Student's t-test for continuous variables or Pearson's χ 2 test for categorical variables. Hardy-Weinberg equilibrium for all SNP allele frequencies among controls was tested using a goodness-of-fit χ 2 test. The associations between miRNA SNPs and RCC susceptibility were estimated by computing odds ratios and 95% confidence intervals (CIs) from unconditional logistic regression analyses. Bonferroni correction was applied for multiple comparison. Each corrected P value was from the derived P value multiplying by tests number, and then it was compared with 0.05 of alpha value (18) . Four genetic models (additive, dominant, recessive and codominant) were used to assess the significance of SNPs. The heterogeneity between subgroups was estimated with the χ 2 based on Q-test. The survival-time curves were estimated using Kaplan-Meier method and comparisons were calculated by the log-rank test. Survival time was calculated from the date of RCC diagnosis to the date of death or last follow-up. Cox proportional hazards models were used to calculate hazard ratios and their 95% CIs for predicting factors of RCC survival. Differences in luciferase reporter assays, as well as miRNA expression levels, were evaluated by Student's t-test or one-way analysis of variance. All P < 0.05 for two-side were considered statistically significant.
Results
Characteristics of study population
The demographic and clinical features of individuals in two sets are listed in Table I . No significant differences between cases and controls in two sets were found with regard to age, sex, body mass index, smoking status, drinking status and family history of cancer (all P > 0.05). However, there were more individuals with hypertension and diabetes in cases than that in controls in each set (all P < 0.05), especially in combined set (both P < 0.001), suggesting that hypertension and diabetes may be important parts in the etiology of RCC.
Associations between selected SNPs in miRNAs and RCC risk
As shown in Table II , all genotype frequencies of SNPs among the control in each set were in agreement with Hardy-Weinberg equilibrium.
In discovery set, rs2292832 in miR-149 and rs11614913 in miR-196a2 were significantly associated with RCC risk (P = 0.021 and P = 0.007 in additive model, respectively), but the significance of miR-149 rs2292832 disappeared after Bonferroni correction (P = 0.084). Thus, we processed validation set for miR-196a2 rs11614913, identifying that rs11614913 was consistently associated with RCC risk only in recessive model (P = 0.042). Nevertheless, in combined set, the variant allele of rs11614913 was significantly associated with a decreased risk of RCC (odds ratio = 0.83, 95% CI = 0.73-0.94, P = 0.004 in additive model). When performing stratified analysis by individual-related and clinical variables (Supplementary Figure S1 , available at Carcinogenesis Online and Supplementary Table S1, available at Carcinogenesis Online), we observed a protective effect of rs11614913 C allele among subjects with lower age and body mass index, with hypertension, without diabetes, family history of cancer subgroups and among patients in early stage and grade (all P ≤ 0.002). However, we did not find association of rs11614913 genotype and clinical features (Supplementary Table S2 , available at Carcinogenesis Online).
In addition, interaction effect analyses between rs11614913 polymorphism and each demographic variable (Supplementary Figure  S1 , available at Carcinogenesis Online and Supplementary Table S3 , available at Carcinogenesis Online) presented no significant heterogeneity and multiplicative interactions in each subgroup (all P > 0.05).
Effects of miR-196a2 rs11614913 on RCC survival
The clinical follow-up data was used to investigate effects of miR-196a2 rs11614913 on RCC patients' survival. The median follow-up time was 19.7 months (0.63-72 months) for 311 RCC cases. The characteristics and clinical features of RCC patients are listed in Supplementary  Table S4 , available at Carcinogenesis Online. As presented in Table III and Figure 1 , individuals with C variant allele had higher 5-year survival rate compared with the corresponding TT wild genotype (hazard ratio = 0.40, 95% CI = 0.26-0.91; log-rank P = 0.002), especially in stage I/II (log-rank P = 0.002). The stratified analysis presented a significant decreased risk of death among never smokers, cases without diabetes and family history of cancer (all P < 0.05, Supplementary 
Correlation analysis between rs11614913 genotypes and expression of miR-196a-5p
We assessed miR-196a-5p expression in 26 RCC tissues with different genotypes by TaqMan miRNA assay. Compared with individuals carrying at least one T allele (TT and TC genotypes), individuals carrying CC genotype had lower levels of miR-196a-5p expression (P = 0.018; Figure 2 ), suggesting that rs11614913 SNP could influence miR-196a-5p expression.
Binding effect of miR-196a2 rs11614913 on potential target genes of miR-196a-3p
Upon bioinformatics analyses (Supplementary Table S7 , available at Carcinogenesis Online and Figure 3 ), 3′-UTRs of LSP1, NRP2 and TYMS have one or two presumed binding sites in conserved regions to the seed region of miR-196a-3p. Furthermore, significantly lower levels of relative luciferase expression were observed when we cotransfected psiCHECK-2-NRP2 or LSP1 with pPG-miR-196a2-C comparing with pPG-miR-196a2-T (all P < 0.05). Although no statistical difference was presented between TYMS reporter plasmid and miR-196a2 C/T expression plasmids, the luciferase expression was lower in pPG-miR-196a2-C than in pPG-miR-196a2-T.
Discussion
In this study, we identified that rs11614913 variant homozygote CC genotype in miR-196a2 significantly decreased RCC risk, and the C allele was associated with a 0.4-fold-reduced hazard ratio for RCC survival. We also observed that the T to C substitution in miR-196a2 rs11614913 substantially altered miR-196a-5p expression as well as targets binding ability of miR-196a-3p. It has been demonstrated that abnormal expression of a specific miRNAs is linked to pathological processes of cancer (26) . Calin et al. (27) firstly observed that miR-15 and miR-16 were abnormal expression among patients with B-cell chronic lymphocytic leukemia and mutations in miR-15a and miR-16-1 were associated with chronic lymphocytic leukemia prognosis and progression. However, the precise mechanisms of altered miRNA expression are ambiguous, and the low penetrance genetic effect of miRNA SNPs on cancer susceptibility and prognosis is not clear. Review by Ryan et al. (16) summarized three ways of miRNA SNPs function: by transcription of the primary transcript; through procession of pri-/pre-miRNA and by effects on miRNA-targets interactions, suggesting that SNPs in miRNA genes might have relevance to cancer development and progression, even the outcome. Hu et al. (24) firstly indicated that rs11614913 SNP was associated with poor survival in non-small cell lung cancer and could influence mature miR-196a expression, but not the pre-miR196a2 level, and even affected the binding ability of miR-196a-3p to its target. Subsequently, Hoffman et al. (28) found that C allele variant was associated with significantly increased breast cancer susceptibility, which was further supported in other cancers (29, 30) , besides he observed that the mature miR-196a-3p expression was not affected by the SNP. However, Wang et al. (31) showed that CC genotype was linked to reduced risk of gastric cancer in Chinese population. Besides, rs11614913 was not found to contribute to gallbladder cancer (32) and colorectal cancer (33) . Especially, Horikawa et al. (34) firstly investigated the association of miRNA-related genes and RCC risk in Caucasians, but there were no significant relationships of rs11614913 and rs2910164 polymorphisms to RCC susceptibility, in which rs11614913 SNP deviated from Hardy-Weinberg equilibrium in their population. Generally, ethnic differences in genetic backgrounds and geographical variations of lifestyle would contribute to different genetic effects (35) . The rs11614913 SNP is a common allele in Chinese population, in which the minor allele is C allele and its frequency is 0.341 in CHB (Han Chinese in Beijing, China) of HapMap phase 3. Whereas, T allele is as the minor allele of CEU (Utah residents with Northern and Western European ancestry from the CEPH collection) and YRI (Yoruba in Ibadan, Nigeria), in which its frequencies are 0.442 and 0.146, respectively. The opposite genetic effects suggest that the molecular mechanisms underlying the genetic associations of miRNA SNPs with cancer are complex, which may relate to the diversity on race-/tissue-specific, tumorigenesis and processing.
Furthermore, many studies have demonstrated that RCC is a heterogeneous disease each caused by a different gene. Moore et al. (14) demonstrated that the von Hippel-Lindau inactivation could be as a biomarker of RCC heterogeneity and its germline alterations were a hereditary syndrome associated with clear-cell renal cancer. Besides, Gardie et al. (15) found that 21 novel fumarate hydratase mutations were associated with type 2 papillary RCC. Nevertheless, the association studies of miR-196a2 rs11614913 polymorphism and any subtypes of RCC risk or survival have not been reported widely.
Thus, in our study, four common SNPs located in miRNA genes (miR-146a rs2910164 C>G, miR-149 rs2292832 T>C, miR-196a2 rs11614913 T>C and miR-499 rs3746444 T>C) were evaluated their associations with RCC susceptibility, including clear-cell and nonclear cell RCC, and further functional relevance. Two-stage cohorts analyses revealed that whatever the subtype of RCC, miR-196a2 rs11614913 was linked to significantly decreased RCC risk, especially the CC genotype had 0.5-fold decreased odds ratio for RCC risk. Furthermore, the follow-up study presented that the variant of rs11614913 could significantly increase RCC survival.
It has been known that miRNAs aberrant expressions are closely related to biological and clinical features of specific tumors in humans (11, 36) . In this study, by detecting miR-196a-5p expression from RCC tissues with different genotypes of rs11614913 polymorphism, we observed that miR-196a-5p expression among patients with CC genotype was markedly lower than the T allele, suggesting that rs11614913 polymorphism might influence the processing of mature miR-196a-5p, thus it might give a reason that the genetic variant of miR-196a2 decreased RCC susceptibility and increased RCC survival.
Some researchers reported that SNPs located in mature miRNAs region could potentially influence the target binding ability of itself (24, 28) . By retrieving dbSNP build 137 (http://ncbi.nlm.nih.gov/ SNP), we found that miR-196a2 rs11614913 SNP was located in mature miR-196a-3p region, which was incorporated as our object of study. Upon integrated bioinformatics, we chose NRP2 and TYMS as candidate RCC-related targets of miR-196a-3p, and LSP1 was selected as a validation target (24). Wild et al. (37) pointed NRPs expression was correlated with tumor growth, invasion and prognosis in various tumor types, besides NRP2 was exhibited strong positive staining in RCC tissue. High expression of TYMS was associated with a poor survival in gastric cancer (38) , and the level of TYMS activity demonstrated correlation with the processing of RCC stage and grade (23) . Luciferase reporter assays presented that the expression of NRP2, TYMS and LSP1 were inhibited by miR-196a2 rs11614913 C allele compared with the T allele, which explained that SNP in mature miRNA had a potential effect on differential mRNA binding. Therefore, it is biologically plausible that miR-196a2 rs11614913 genetic variant may influence RCC susceptibility and survival by negatively regulating the RCC-related genes (e.g. NRP2 and TYMS), and further, it may provide the basis for RCC prevention and individualized treatment.
Conclusion
In general, this is the first study providing epidemiologic evidence on miRNA SNPs with RCC susceptibility and long-term outcome in Chinese population. Two-stage case-control association analyses with a relatively large population size afforded a high statistical power to perceive subtle differences. However, the individuals for survival analysis were relatively small, especially for stage III/IV. Besides, the precise mechanisms by which the miR-196a2 and its target mRNAs contribute to RCC susceptibility and survival are not fully clear. To explore in depth whether miR-196a2 rs11614913 could serve as a biological marker, further mechanism studies in vitro and in vivo are warranted.
Supplementary material
Supplementary Tables S1-S7 and Figure S1 can be found at http:// carcin.oxfordjournals.org/
